Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse J Balic

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
International Journal of Cancer|February 9, 2018
Hyperactive gp130/STAT3-driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure developmentDavid G Hill, Liang Yu, Hugh Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2018
Clinical Utility of a STAT3-Regulated miRNA-200 Family Signature with Prognostic Potential in Early Gastric CancerLiang Yu, Di Wu, Hugh Gao, et al.
The American Journal of Pathology|March 24, 2020
Constitutive STAT3 Serine Phosphorylation Promotes Helicobacter-Mediated Gastric DiseaseJesse J Balic, Mohamed I Saad, Ruby Dawson, et al.
Oncogene|October 20, 2021
Complete loss of miR-200 family induces EMT associated cellular senescence in gastric cancerLiang Yu, Can Cao, Xu Li, et al.
Nature Communications|August 1, 2020
STAT3 serine phosphorylation is required for TLR4 metabolic reprogramming and IL-1β expressionJesse J Balic, Hassan Albargy, Kevin Luu, et al.
Gut|September 7, 2021
STAT3-mediated upregulation of the AIM2 DNA sensor links innate immunity with cell migration to promote epithelial tumourigenesisRuby E Dawson, Virginie Deswaerte, Alison C West, et al.
Nature|December 9, 2021
Non-genetic determinants of malignant clonal fitness at single-cell resolutionKatie A Fennell, Dane Vassiliadis, Enid Y N Lam, et al.
Nature Immunology|November 21, 2024
A STAT3-STING-IFN axis controls the metastatic spread of small cell lung cancerAleks C Guanizo, Quinton Luong, W Samantha N Jayasekara, et al.
EMBO Molecular Medicine|March 6, 2019
ADAM17 selectively activates the IL-6 trans-signaling/ERK MAPK axis in KRAS-addicted lung cancerMohamed I Saad, Sultan Alhayyani, Louise McLeod, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
International Journal of Cancer|February 9, 2018
Hyperactive gp130/STAT3-driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure developmentDavid G Hill, Liang Yu, Hugh Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2018
Clinical Utility of a STAT3-Regulated miRNA-200 Family Signature with Prognostic Potential in Early Gastric CancerLiang Yu, Di Wu, Hugh Gao, et al.
The American Journal of Pathology|March 24, 2020
Constitutive STAT3 Serine Phosphorylation Promotes Helicobacter-Mediated Gastric DiseaseJesse J Balic, Mohamed I Saad, Ruby Dawson, et al.
Oncogene|October 20, 2021
Complete loss of miR-200 family induces EMT associated cellular senescence in gastric cancerLiang Yu, Can Cao, Xu Li, et al.
Nature Communications|August 1, 2020
STAT3 serine phosphorylation is required for TLR4 metabolic reprogramming and IL-1β expressionJesse J Balic, Hassan Albargy, Kevin Luu, et al.
Gut|September 7, 2021
STAT3-mediated upregulation of the AIM2 DNA sensor links innate immunity with cell migration to promote epithelial tumourigenesisRuby E Dawson, Virginie Deswaerte, Alison C West, et al.
Nature|December 9, 2021
Non-genetic determinants of malignant clonal fitness at single-cell resolutionKatie A Fennell, Dane Vassiliadis, Enid Y N Lam, et al.
Nature Immunology|November 21, 2024
A STAT3-STING-IFN axis controls the metastatic spread of small cell lung cancerAleks C Guanizo, Quinton Luong, W Samantha N Jayasekara, et al.
EMBO Molecular Medicine|March 6, 2019
ADAM17 selectively activates the IL-6 trans-signaling/ERK MAPK axis in KRAS-addicted lung cancerMohamed I Saad, Sultan Alhayyani, Louise McLeod, et al.
Pageof 2